Login
Home
Charts
Search
Watchlist
Products

Mercury Laboratories Ltd

MERCURYLAB·BSE
₹817.00+0.06%Tue, 22 Sept '26 13:35
Industry:Pharma - Formulators
Indices:

Mercury Laboratories Ltd

MERCURYLAB
BSE
₹817.00
+0.06%
|Tue, 22 Sept '26 13:35
SOICxStockScans Reports
Industry
Pharma - Formulators
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹98Cr
Close
Close Price
₹817.00
Industry
Industry
Pharma - Formulators
PE
Price To Earnings
23.55
PS
Price To Sales
1.33
Revenue
Revenue
₹74Cr
Rev Gr TTM
Revenue Growth TTM
-3.66%
PAT Gr TTM
PAT Growth TTM
10.61%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
231717171820211819182016
Growth YoY
Revenue Growth YoY%
3.15.4-10.6-8.9-20.114.418.98.84.5-6.2-1.1-12.0
Expenses
ExpensesCr
201515151718191617161815
Operating Profit
Operating ProfitCr
323212222321
OPM
OPM%
11.013.015.39.77.210.110.313.011.213.79.97.5
Other Income
Other IncomeCr
000001001010
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
222112122120
Tax
TaxCr
100100010010
PAT
PATCr
212011112110
Growth YoY
PAT Growth YoY%
-51.9103.3416.2-66.0-66.9-4.0-41.9185.3228.0-16.010.8-69.1
NPM
NPM%
6.67.311.02.02.86.15.45.38.65.56.01.9
EPS
EPS₹
12.610.315.92.94.29.99.38.113.78.310.22.5
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
231717171820211819182016
Growth YoY
Revenue Growth YoY%
3.15.4-10.6-8.9-20.114.418.98.84.5-6.2-1.1-12.0
Expenses
ExpensesCr
201515151718191617161815
Operating Profit
Operating ProfitCr
323212222321
OPM
OPM%
11.013.015.39.77.210.110.313.011.213.79.97.5
Other Income
Other IncomeCr
000001001010
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
222112122120
Tax
TaxCr
100100010010
PAT
PATCr
212011112110
Growth YoY
PAT Growth YoY%
-51.9103.3416.2-66.0-66.9-4.0-41.9185.3228.0-16.010.8-69.1
NPM
NPM%
6.67.311.02.02.86.15.45.38.65.56.01.9
EPS
EPS₹
12.610.315.92.94.29.99.38.113.78.310.22.5

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
484852565769587576757674
Growth
Revenue Growth%
15.41.18.07.03.119.8-15.630.10.3-0.61.1-3.7
Expenses
ExpensesCr
414147505159516767686766
Operating Profit
Operating ProfitCr
6746610799798
OPM
OPM%
13.614.08.510.310.814.012.111.411.99.311.910.7
Other Income
Other IncomeCr
100111121121
Interest Expense
Interest ExpenseCr
111111000111
Depreciation
DepreciationCr
111222223333
PBT
PBTCr
552448577575
Tax
TaxCr
120113121221
PAT
PATCr
432335466354
Growth
PAT Growth%
18.4-31.1-25.540.913.865.3-33.356.61.4-44.453.710.6
NPM
NPM%
8.35.63.95.15.67.86.27.47.54.26.45.7
EPS
EPS₹
32.722.516.823.626.944.529.746.547.126.240.334.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
484852565769587576757674
Growth
Revenue Growth%
15.41.18.07.03.119.8-15.630.10.3-0.61.1-3.7
Expenses
ExpensesCr
414147505159516767686766
Operating Profit
Operating ProfitCr
6746610799798
OPM
OPM%
13.614.08.510.310.814.012.111.411.99.311.910.7
Other Income
Other IncomeCr
100111121121
Interest Expense
Interest ExpenseCr
111111000111
Depreciation
DepreciationCr
111222223333
PBT
PBTCr
552448577575
Tax
TaxCr
120113121221
PAT
PATCr
432335466354
Growth
PAT Growth%
18.4-31.1-25.540.913.865.3-33.356.61.4-44.453.710.6
NPM
NPM%
8.35.63.95.15.67.86.27.47.54.26.45.7
EPS
EPS₹
32.722.516.823.626.944.529.746.547.126.240.334.7

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
11111111111
Reserves
ReservesCr
2123252831363944505257
Current Liabilities
Current LiabilitiesCr
2017131715191614131512
Non Current Liabilities
Non Current LiabilitiesCr
410121191064469
Total Liabilities
Total LiabilitiesCr
4751525756656264687479
Current Assets
Current AssetsCr
2831303232383539403945
Non Current Assets
Non Current AssetsCr
1920222525282725283534
Total Assets
Total AssetsCr
4751525756656264687479
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
11111111111
Reserves
ReservesCr
2123252831363944505257
Current Liabilities
Current LiabilitiesCr
2017131715191614131512
Non Current Liabilities
Non Current LiabilitiesCr
410121191064469
Total Liabilities
Total LiabilitiesCr
4751525756656264687479
Current Assets
Current AssetsCr
2831303232383539403945
Non Current Assets
Non Current AssetsCr
1920222525282725283534
Total Assets
Total AssetsCr
4751525756656264687479

Cash Flow

Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
55852854
Investing Cash Flow
Investing Cash FlowCr
-5-1-5-2-1-6-9-3
Financing Cash Flow
Financing Cash FlowCr
-3-3-1-1-1-1-23
Net Cash Flow
Net Cash FlowCr
-212201-64
Free Cash Flow
Free Cash FlowCr
044312-41
CFO To PAT
CFO To PAT%
184.2170.1153.9145.744.0145.5154.587.7
CFO To EBITDA
CFO To EBITDA%
91.389.185.674.228.691.169.246.9
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
55852854
Investing Cash Flow
Investing Cash FlowCr
-5-1-5-2-1-6-9-3
Financing Cash Flow
Financing Cash FlowCr
-3-3-1-1-1-1-23
Net Cash Flow
Net Cash FlowCr
-212201-64
Free Cash Flow
Free Cash FlowCr
044312-41
CFO To PAT
CFO To PAT%
184.2170.1153.9145.744.0145.5154.587.7
CFO To EBITDA
CFO To EBITDA%
91.389.185.674.228.691.169.246.9

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5248474134775870100988498
Price To Earnings
Price To Earnings
13.417.823.214.310.414.416.312.617.731.317.423.6
Price To Sales
Price To Sales
1.11.00.90.70.61.11.00.91.31.31.11.3
Price To Book
Price To Book
2.42.01.81.41.12.11.41.52.01.81.41.7
EV To EBITDA
EV To EBITDA
8.98.011.98.36.18.28.28.010.814.59.512.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
53.553.249.147.250.250.354.953.857.459.058.658.6
OPM
OPM%
13.614.08.510.310.814.012.111.411.99.311.910.7
NPM
NPM%
8.35.63.95.15.67.86.27.47.54.26.45.7
ROCE
ROCE%
21.418.19.313.713.419.811.815.212.98.810.810.8
ROE
ROE%
17.911.17.69.810.114.58.812.211.15.98.38.3
ROA
ROA%
8.45.33.95.05.78.25.78.78.34.26.16.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5248474134775870100988498
Price To Earnings
Price To Earnings
13.417.823.214.310.414.416.312.617.731.317.423.6
Price To Sales
Price To Sales
1.11.00.90.70.61.11.00.91.31.31.11.3
Price To Book
Price To Book
2.42.01.81.41.12.11.41.52.01.81.41.7
EV To EBITDA
EV To EBITDA
8.98.011.98.36.18.28.28.010.814.59.512.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
53.553.249.147.250.250.354.953.857.459.058.658.6
OPM
OPM%
13.614.08.510.310.814.012.111.411.99.311.910.7
NPM
NPM%
8.35.63.95.15.67.86.27.47.54.26.45.7
ROCE
ROCE%
21.418.19.313.713.419.811.815.212.98.810.810.8
ROE
ROE%
17.911.17.69.810.114.58.812.211.15.98.38.3
ROA
ROA%
8.45.33.95.05.78.25.78.78.34.26.16.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Mercury Laboratories Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/1nlfycn7qnfowjykybtbxuc0.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/17hh6c0illb71wjcg8eb83xi.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/bbp7m30de4f2w3rffghzz51g.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/cxrwvq2t22ebt5wjmhe72p2a.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/4znd0gptozw0yfjl13332jqt.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/ditlqba9ph7d2kaz5sm7j9jy.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/rztbsfwuzf93z3a2lhy12n15.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/s5osucukh0eybhyztkd2lza5.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/03gjf1cvwjs97v3rgassesbk.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/k3mfadalx8xa953gibzdihh3.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/o0thzb8f4xlwolefyjd5ivvz.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/zcn3wdcs88l8vmeturolvjmb.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/73opc96bwtb67awja1kqqeic.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/114gay81gskhyn62yh25o3d1.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/hxq6hh0mwcypkyu7vyr013z2.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies